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Abstract 
Objective: Autophagy is the regulated catabolic process for recycling damaged or 
unnecessary organelles, which plays crucial roles in cell survival during nutrient 
deficiency, and innate immune defense against pathogenic microorganisms. Autophagy 
has been also reported to be involved in various conditions including inflammatory 
diseases. IRGM (human immunity-related GTPase) has an important function in 
eliminating Mycobacterium tuberculosis from host cells via autophagy. We examined 
the association between genetic polymorphism and clinical course/outcome in patients 
with severe sepsis.  
Methods: The study included 125 patients with severe sepsis/septic shock (SS) and 104 
non-sepsis patients who were admitted to the ICU of Chiba University Hospital between 
October 2001 and September 2008 (discovery cohort) and 268 SS patients and 454 
non-sepsis patients who were admitted to the ICU of five Japanese institutions including 
Chiba University Hospital between October 2008 and September 2012 (multi-center 
validation cohort). Three hundred forty seven healthy volunteers who consented to this 
study were also included. Genotyping was performed for a single-nucleotide 
polymorphism (SNP) within the coding region of the IRGM, IRGM(+313) (rs10065172). 
Lipopolysaccharide challenge of whole blood from randomly selected healthy 
volunteers (n=70) was performed for comparison of IRGM mRNA expression among 
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different genotypes. 
Results: No significant difference in genotypic distributions (CC/CT/TT) at the 
IRGM(+313) locus was observed among the three subject groups (SS, non-sepsis, and 
healthy volunteers) in either cohort. When mortality were compared, no significant 
difference was observed in the non-sepsis group, while TT homozygotes exhibited a 
significantly higher mortality than the CC+CT genotype category in the SS group for 
both cohorts (P=0.012,0.036). Lipopolysaccharide challenge of whole blood from 
healthy volunteers showed a significant suppression of IRGM mRNA expression in TT 
homozygotes compared with the CC+CT genotype category (P=0.019). 
Conclusions: The data suggest that IRGM(+313) SNP, an autophagy-related 
polymorphic locus, influences outcome in patients with severe sepsis, with the possible 
involvement of autophagy in sepsis exacerbation. 
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I．Introduction 
Severe sepsis is the host inflammatory response to infection with presence of organ 
dysfunction [1]. It is a critical condition that is very difficult to survive, as indicated by 
high mortality rates ranging from 30% and 80% in various countries [2,3]. After 
overcoming the acute inflammatory response phase and remission of SIRS, septic 
patients go into an anti-inflammatory phase, which is even more difficult to overcome 
(CARS; compensatory anti-inflammatory response syndrome). The subsequent 
development of immunoparalysis is believed to affect the prognosis of sepsis, 
particularly during the post-acute phase [4-6]. 
Apoptosis (type I programmed cell death) of immune effector cells plays a crucial 
role in the pathophysiology of CARS and immunoparalysis in sepsis, and the regulation 
of apoptosis is expected to improve survival in sepsis [7,8]. On the other hand, the 
involvement of autophagy (type II programmed cell death) in the pathophysiology of 
sepsis has attracted the attention of both researchers and clinicians [9,10]. Autophagy 
("self-eating"), a regulated catabolic process, has roles in the degradation of unnecessary 
organelles, elimination of pathogenic microorganisms, and tumor suppression [11]. 
Sepsis-induced organ failure is considered to be the summation of cellular dysfunction 
induced by cell death of different cells [12], and vital organ failure may be related to 
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immune system abnormalities. Recently, the genome-wide association study (GWAS) 
approach has enabled systematic searches of disease susceptibility genes. Using this 
methodology, an autophagy-related gene, autophagy-related protein 16-like 1 
(ATG16L1), was identified as a disease susceptibility gene closely involved in the 
pathophysiology of Crohn's disease, an inflammatory bowel disease [13]. In addition, an 
association between IRGM (a human immunity-related GTPase) expression and the 
induction and execution of autophagy upon bacterial infections, such as tuberculosis, 
has been reported with regulation of autophagy formation in proportion to IRGM 
expression [14]. Furthermore, genetic polymorphism of IRGM has been confirmed to be 
involved in the development of inflammatory bowel disease and in the induction of 
autophagy [15]. 
To investigate how autophagy is involved in the pathophysiology of severe 
sepsis/septic shock, i.e., a highly systemic inflammatory disease, we examined the 
association between a single-nucleotide polymorphism (SNP) in the autophagy-related 
IRGM gene and clinical outcomes in severe sepsis for two cohorts (one single-center 
cohort and one multi-center cohort) in Japanese population. We also examined the 
mRNA expression of autophagy-related SNP under stimulus by lipopolysaccharide 
(LPS) ex vivo. 
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II．Material and Methods 
1. Discovery cohort 
After approval by the institutional ethics committee, written informed consent from 
patients or their next of kin was obtained. In discovery cohort, 259 critically ill patients 
admitted to the general intensive care unit (ICU) of Chiba university hospital in Chiba, 
Japan, between October 2001 and September 2008. Inclusion criteria were admitted to 
the ICU, 18 years of age or older, patients capable of obtaining informed consent in 
writing own, family, or the legal representative. Exclusion criteria included pregnancy, 
treatment in the hematologic malignancies, patients receiving radiation treatment and 
chemotherapy, history of genetic therapy, and outside the scope of active treatment. 
Blood samples were obtained immediately after admission to the ICU. Centrifuged 
blood samples were kept separate blood cells and serum at -80℃. The genomic DNA 
was extracted from whole blood cells. 
 
2. Multi-center validation cohort 
In multi-center validation cohort, 793 critically ill patients admitted to the five general 
ICU including the five tertiary medical centers, or Kurume University Hospital, Tokyo 
Medical University Hachioji Medical Center, Hyogo College of Medicine, Kimitsu 
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Chuo Hospital and Chiba University Hospital from October 2008 to September 2012. 
Inclusion and exclusion criteria were the same as the discovery cohort. On admission 
the ICU, Blood samples were obtained. The blood cells were refrigerated and collected 
to Chiba University Hospital, and the genomic DNA was thereafter extracted. 
 
3. Data collection 
Baseline characteristics (age, gender), as well as clinical data including length of ICU 
stay, Sequential Organ failure Assessment (SOFA) scores [16], Acute Physiology and 
Chronic Health Evaluation (APACHE)Ⅱ scores [17], morbidity of severe sepsis and 
septic shock, ICU mortality were obtained after the patients were documented at study 
entry. The APACHEⅡ scores and SOFA scores were calculated in the first 24 hours 
after admission. 
The diagnosis of systemic inflammatory response syndrome (SIRS) and sepsis, severe 
sepsis and septic shock were based on the criteria presented at the American College of 
Chest Physicians / Society of Critical Care Medicine Consensus Conference in 1992 
[18]. In the present study, both severe sepsis and septic shock is expressed together as 
SS group. 
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4. IRGM(+313) (rs10065172) genotyping 
Genomic DNA was extracted from ethylenediaminetetraacetic acid anticoagulated 
blood using Qiagen’s QIAamp DNA Minikit (Qiagen, Valencia, CA) according to 
manufacturer’s instructions. We amplified the target region of DNA by polymerase 
chain reaction (PCR) with primers (Applied Biosystems, Foster City, CA) specific for 
the sequence of IRGM(+313) (rs10065372), a SNP which presents at the position of 
+313 inside the exon 2 of IRGM in the chromosome 5q33.1 [19,20]. Each 25 L of PCR 
mixture contained 20 ng of genomic DNA, 900 nM primers, 250 nM probes, and 12.5  
L of TaqMan○
R
 Universal PCR master mix (Applied Biosystems, Foster City, CA), 
which is a solution containing buffer, uracil-N-glycosylase, deoxyribonucleotides, 
uridine, passive reference dye (ROX), and TadGold DNA polymerase. Amplification 
was done under the following conditions: 50℃ for 2 min, 95℃ for 10 min, and 40 
cycles at 92℃ for 15 sec and 60℃ for 1 min. Fluorescence in each well was measured 
before and after PCR using an ABI PRISM 7000 Sequence Detection System (Applied 
Biosystems, Foster City, CA).  
 
5. IRGM mRNA expression ex vivo 
The subjects were 347 healthy volunteers who consented to this study. Extraction of 
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genomic DNA and IRGM polymorphisms were analyzed by the method described 
above. 
The randomly selected 70 healthy volunteers, whole blood mixed 10mL：10mL with 
cell culture medium (RPMI 1640 (Wako, Tokyo, Japan)) were transferred to 12-well 
microtiter plates (Falcon, Mountain View, CA). Samples were incubated at 37℃ and 
5% CO2 with endotoxin (lipopolysaccharide, 1ng/mL; from Salmonella friedenau) for 4 
hours. Control mixtures were incubated without endotoxin. After incubation, the 
supernatants were separated and stored frozen at -80℃. 300 L of the RNA protect Cell 
Reagent (Qiagen, Valencia, CA) was added to the blood cell component after 
centrifugation, and the mixture was stored at -80℃. Each mRNA was extracted using 
QIAamp RNA Blood Mini Kit (Qiagen, Valencia, CA) from the blood cells. The mRNA 
was reversed transcribed into complementary DNA (cDNA) using the High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) according to 
the manufacturer’s instructions. Real-time PCR with specific fluorescence-labeled probe 
was used to quantify mRNA expression of IRGM. The reaction was performed in 
96-well microtiter plates with an ABI PRISM 7000 Sequence Detection System. 
Primers (glyceraldehyde-3-phosphate dehydrogenase; Assay ID: Hs03929097_g1, 
Applied Biosystems, Foster City, CA) and regents were purchased from Applied 
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Biosystems Inc.. PCR reactions were performed in a total volume of 50 L containing 
cDNA samples, TaqMan○
R
 Universal PCR master mix (Applied Biosystems, Foster City, 
CA). TaqMan○
R
 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) endogenous 
control reagent was used as internal control for normalization. Amplification was 
performed under the following conditions： 50℃ for 2 min, 95℃ for 10 min, 40 cycles 
at 95℃ for 15 sec, and 60℃ for 1 min. Fluorescence in each well was measured using 
an ABI PRISM 7000 Sequence Detection System. The mRNA expression levels were 
assessed by relative quantification (RQ). Cycle threshold values for IRGM gene were 
determined and abundance in comparison to GAPDH was calculated. qRT-PCR results 
were recorded for IRGM gene as fold change of LPS stimulated vs non-stimulated 
blood at 4h using C(t) method [21]. PCR products were evaluated by dissociation 
curves to confirm single amplicons and the absence of significant primer–dimer 
contamination. 
 
6. Statistical Analysis 
We performed a multivariable logistic regression analysis applying a forced entry 
method with SPSS software (SPSS Inc, Chicago, IL) in order to assess risk factors, 
including heritable and acquired conditions, which are considered to be associated with 
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outcome of critical illnesses.  
The Hardy-Weinberg equilibrium for the population distribution of the variant alleles 
was determined according to the approach described by Guo and Thompson [22]. 
Allelic chi-squares were examined for each SNP. We considered the differences 
significant with respect to mortality at a full scan permutation of the correlation/trend 
test P-value of <0.05. Fold change, or RQ, was calculated to determine the magnitude 
of difference in gene expression and a Student’s t-test P-value was performed to 
demonstrate the reproducibility of the changes observed in the IRGM gene after LPS 
challenge. We compared the variables in different groups using the unpaired Student’s 
t-test and Mann-Whitney U test, depending on the type of variable. Statistical 
significance was defined as P<0.05. Statistical analyses were performed with the 
GraphPad Prism 5 software package for Windows (GraphPad Software, CA , USA).  
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III．Results 
Baseline Characteristics of Discovery Cohort and Multi-Center Validation Cohort 
Table 1 summarizes the baseline characteristics of the discovery cohort (n = 259) and 
the multi-center validation cohort (n = 793). No significant difference in age, gender, or 
length of ICU stay was observed between the two cohorts. In addition, no significant 
difference in SOFA or APACHE II score was detectable between the two cohorts, which 
indicated that there was no marked difference in patient backgrounds between the two 
cohorts. The incidence and mortality rates of severe sepsis/septic shock tended to be 
greater in the discovery cohort, but the difference was not statistically significant. 
For the comparison of patient backgrounds, patients with severe sepsis/septic shock in 
each of the two cohorts were further divided into two categories based on IRGM(+313) 
(rs10065172) genotype: CC+CT and TT (Table 2). No significant difference in age, 
gender, length of ICU stay, or SOFA score was observed between the two genotype 
categories in either cohort. A significant difference in APACHE II score between 
genotype categories was observed only in the discovery cohort: TT homozygotes 
exhibited a significantly higher APACHE II score than CC+CT genotypes (26.5 ± 8.1 vs. 
21.3 ± 8.1, P = 0.031). 
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Genotype Distributions 
Table 3 summarizes the genotype distributions in all subjects of the present study. The 
subjects were divided into three groups (severe sepsis/septic shock (SS), non-sepsis, and 
healthy volunteers) for comparison of distribution of the three genotypes (CC, CT, and 
TT). As shown in Table 3, no apparent difference in the percentages of the CC/CT/TT 
genotypes was observed among the three groups.  
 
Comparison of mortality rate 
For both of the cohorts, the mortality rate was compared between two different 
genotype categories separately within the non-sepsis and SS groups. For the discovery 
cohort, no significant difference in mortality was observed between the CC+CT 
genotype and TT homozygotes in the non-sepsis group, while TT homozygotes 
exhibited a significantly higher mortality rate than the CC+CT genotype in the SS group 
(P = 0.012) (Fig. 1a). Similar results were obtained for the multi-center validation 
cohort (P = 0.036) (Fig. 1b). 
When the two cohorts were combined and analyzed in a similar manner for validation, 
the statistical significance of the difference in mortality rate between the two genotype 
categories was even greater (P = 0.007) (Fig. 1c). 
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Ex vivo LPS challenge and mRNA assay 
The genotype distribution in the healthy volunteer group (n = 347) was not apparently 
different from that in either the SS group or the non-sepsis group (Table 3). When ex 
vivo LPS challenge and mRNA assays were performed for 70 subjects in the healthy 
volunteer group, the mean RQ for the TT homozygotes (-0.3465, SD = 0.1133) was 
significantly lower than the values for the CC homozygote (1.427, SD = 0.5809) and the 
CT heterozygote (0.6702, SD = 0.1702) (P = 0.019) (Table 4). 
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IV．Discussion 
As described above, we demonstrated that TT homozygosity at the IRGM(+313) 
(rs10065172) SNP locus, an autophagy-related genetic polymorphism, was associated 
with a significantly higher mortality rate in SS group patients in two cohorts, a 
single-center cohort and a multi-center cohort. When the two cohorts were combined 
and analyzed in a similar manner for validation, the statistical significance of the 
difference in mortality rate between TT homozygotes and the CC+CT genotype 
category was even greater. In addition, when whole blood was exposed to stimulus by 
LPS and IRGM mRNA expression was assayed, the amount of mRNA expressed was 
significantly lower in the TT homozygotes.  
The development of organ dysfunction in severe sepsis may be ascribable to the 
dysfunction or death of cells constituting the deteriorated organ [12]. While cell death 
induced by cellular dysfunction has traditionally been interpreted as the result of 
necrosis, a different type of cell death, apoptosis, was identified as an additional 
mechanism of cell death in sepsis, depending on the cell type [23]. Apoptosis is a 
mechanism of regulated suicide of cells, i.e., programmed cell death, triggered to 
protect an individual. In addition to necrosis and apoptosis, autophagy has recently been 
highlighted as a third mechanism of cell death [7]. 
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eAutophagy is a physiological phenomenon of "self-eating" that involves 
self-degradation of proteins by cells experiencing unfavorable conditions for survival, 
such as a poor nutritional environment, ie. starvation. Autophagy contributes to the 
maintenance of biological homeostasis by recycling proteins and eliminating pathogenic 
microorganisms that invade the cytoplasm [11]. When cells are starved, protein 
synthesis slows down. Autophagy occurs in such a situation to enable cells to transfer 
their own amino acids to other cells. During the process of autophagy, cell organelles 
are incorporated into autophagosomes, which fuse with lysozomes for intracellular 
digestion. Which cells fall into necrosis, apoptosis, or autophagy under a highly invasive 
condition such as sepsis remains controversial [7,10,24-26].  
Autophagy has been reported in a number of cases of sepsis. Watanabe et al. [10] 
observed increased numbers of autophagosomes in the liver cells of patients with severe 
sepsis and further demonstrated increased numbers of autophagosomes in the liver of a 
mouse cecal ligation and puncture (CLP) model of sepsis. Using the same animal model 
of sepsis in GFP-LC3 transgenic mice, Takahashi et al. [27] demonstrated a transient 
increase in autophagic activity during the acute phase of sepsis with subsequent 
stagnation of autophagic flux. While the relationship between autophagy and sepsis is 
beginning to be clarified, the details of their association remain unknown.  
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IRGM was originally identified as a molecule with an important function in 
eliminating Mycobacterium tuberculosis from the host cell via autophagy [28]. We 
believe the present work has major implication for the broader field of sepsis because of 
the similarities between active tuberculosis and protracted sepsis. The possible 
involvement of IRGM polymorphism in the development of Crohn's disease, an 
inflammatory bowel disease, has been reported. Work by Brest et al. [29] implicated a 
variant at the IRGM(+313) locus in the activity of infection control in the intestinal 
epithelia of individuals with Crohn's disease. They demonstrated that a family of 
microRNAs overexpressed under inflammatory conditions formed a complex with 
IRGM mRNA to regulate IRGM production. 
IRGM polymorphism has also been reported to be involved in mitochondrial 
dysfunction. Singh et al. [30] showed that IRGM translocates to the mitochondrial inner 
membrane to regulate mitochondrial nuclear fission. They also reported that the 
overexpression of a particular IRGM isoform caused mitochondrial nuclear fission and 
depolarization as well as autophagy-independent cell death. Furthermore, Carre et al. 
[31] reported that the activation of mitochondrial biogenesis in the skeletal muscle of 
septic patients contributed to a favorable outcome. Watanabe et al. [10] reported that 
liver cells from patients with sepsis had both a reproducible pattern of mitochondrial 
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injury and a marked increase in autophagic vacuolization. Takasu et al. [25] identified 
mitochondrial membrane injury and autophagosome formation in renal proximal tubules 
of septic patients.  
Autophagy and organ failure have recently gained attention in the field of surgical 
nutrition. Vanhorebeek et al. [32] have reported that a relatively fasted state is required 
for proper functioning of autophagy in nutrition support during the first days of critical 
illness. Early overfeeding under a highly invasive condition might lead to the 
insufficient activation of autophagy. This would lead to susceptibility to infections 
resulting from defects in host defense mechanisms as well as abnormal activity of the 
cellular injury repair system. Consequently, the accumulation of various injuries at the 
cellular level would induce organ dysfunction and delay recovery. These undesirable 
factors would ultimately affect each other. We hypothesized that the ‘physiologic’ 
autophagy flux is disturbed in severely septic conditions and this impaired autophagy 
causes the patient deterioration through tissue dysoxia. The less expresser in IRGM SNP, 
or TT homozygotes of IRGM(+313), might cause the harmful effect in the 
pathophysiology of severe sepsis/septic shock.  
The present study has the following limitations: First, the pathogen for sepsis was 
identified in only a limited number of septic patients included in the study. Although the 
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mechanisms of autophagy against different pathogenic microorganisms such as 
Mycobacterium tuberculosis, Listeria, and Toxoplasma are being clarified separately, 
the pathogen was unknown in the majority of our septic patients. Consequently, the 
mechanism of autophagy in each septic patient also remains unknown and must be 
discussed only with respect to sepsis in general.  
Second, the patients studied were admitted to the participating centers over a period 
of 12 years although they were included without any overlaps. The standard treatment 
for severe sepsis/septic shock might not be identical throughout such a long study 
period, and the possible influence of treatment variation on clinical outcome of the 
patients cannot be ruled out.  
Third, the concentration of LPS used in LPS challenge of whole blood collected from 
healthy humans (final concentration, 1 ng/mL) was much higher than that used for LPS 
challenge in animal studies. Regardless of the limitation, a significant suppression of 
IRGM gene expression at the mRNA level in TT variant homozygotes in response to 
LPS in human whole blood cells was observed for the first time in this study. The assay 
of IRGM mRNA in blood collected from patients with severe sepsis for comparison 
among different genetic variants may be of significance in elucidating the genetic 
mechanisms regulating autophagy. However, this approach may not always be easy, 
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since the expression of various genes related to the inflammatory response is known to 
change during the clinical course of sepsis and vary depending on the etiology [33]. 
 
V．Conclusions 
In the present single-center and multi-center prospective study, we demonstrated that 
TT homozygosity at the IRGM(+313) locus, an autophagy-related polymorphic locus, 
affected clinical outcome in patients with severe sepsis. LPS challenge of whole blood 
from healthy volunteers showed significantly reduced expression of IRGM in TT 
homozygotes. The present study suggests the possibility that TT homozygosity at the 
IRGM(+313) locus may be involved in the suppression of IRGM expression in severe 
sepsis, thereby suppressing autophagy and leading to a poor clinical outcome. 
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Figure Legends 
Figure 1.  Comparison of mortality between different genotype categories for SNP at 
IRGM(+313) (rs10065172). (a) The discovery cohort (P=0.012, recessive model of the 
correlation/trend test; TT v (CC+CT) in the 125 SS patients). (b) The multi-center 
validation cohort (P=0.036, recessive model the correlation/trend test; TT v (CC+CT) in 
the 271 SS patients). (c) The combined cohort (P=0.007, recessive model the 
correlation/trend test; TT v (CC+CT) in the 396 SS patients). SS, severe sepsis/septic 
shock 
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Table 1：Baseline characteristics of the study population
Discovery cohort Multi-center validation cohort
All
Non-sepsis 
patients
SS patients P value* All
Non-sepsis 
patients
SS patients P value*
n=259 n=104 n=125 n=793 n=454 n=271
Age (yaers), mean±SD 57±17 57±17 58±17 0.492 64±17 62±18 67±15 0.0008
Male/female gender, n 146/113 61/44 69/56 0.659 517/276 341/181 176/95 0.915
Length of ICU stay (days), mean±SD 12.5±17.3 6.0±7.5 18.5±22 <0.0001 17.3±25 12.7±17.4 26.1±34.9 <0.0001
SOFA score, mean±SD 7.1±5.1 3.8±3.1 10.3±4.6 <0.0001 6.4±4.4 4.8±3.5 9.5±4.2 <0.0001
APACHE II score, mean±SD 16.4±9.0 10.6±6.2 21.9±8.3 <0.0001 17.3±8.8 15.0±8.3 21.8±7.9 <0.0001
Severe sepsis morbidity (%) 48.0 33.8
Mortality (%) 17.0 5.71 29.6 <0.0001 12.2 5.40 25.3 <0.0001
Post-surgical operation
Post-cardiovascular surgery, n(%) 28 (10.8) 24 (23.0) 4 (3.2) 21 (2.6) 5 (1.1) 12 (4.4)
Post-gastrointestinal surgery, n(%) 33 (12.7) 11 (10.6) 15 (12.0) 79 (10.0) 25 (5.5) 43 (15.9)
Others, n(%) 20 (7.7) 12 (11.5) 6 (4.8) 6 (0.8) 3 (0.7) 3 (1.1)
Intracranial disease (ICH/CI), n(%) 5 (2.0) 0 (0) 4 (3.2) 68 (8.6) 62 (13.7) 3 (1.1)
Respiratory failure, n(%) 28 (10.8) 4 (3.8) 22 (17.6) 77 (9.7) 15 (3.3) 51 (18.8)
Heart failure, n(%) 10 (3.9) 4 (3.8) 3 (2.4) 72 (9.1) 61 (13.4) 8 (3.0)
Endogenous abdominal disease
Acute pancreatitis, n(%) 22 (8.5) 16 (15.4) 6 (4.8) 39 (4.9) 22 (4.8) 14 (5.2)
Gastrointestinal bleeding, n(%) 5 (2.0) 2 (1.9) 3 (2.4) 36 (4.5) 33 (7.3) 2 (0.7)
Hepatic failure, n(%) 7 (2.7) 3 (2.9) 4 (3.2) 19 (2.4) 7 (1.5) 9 (3.3)
Others, n(%) 13 (5.0) 1  (1.0) 9 (7.2) 34 (4.3) 10 (2.2) 21 (7.7)
CPAOA, n(%) 4 (1.5) 2 (1.9) 2 (1.6) 39 (4.9) 32 (7.0) 4 (1.5)
Trauma, n(%) 11 (4.3) 9 (8.7) 0 (0) 119 (15.0) 105 (23.1) 8 (3.0)
Intoxication, n(%) 8 (3.1) 4 (3.8) 4 (3.2) 23 (2.9) 17 (3.7) 6 (2.2)
Burn, n(%) 2 (0.8) 1 (1.0) 0 (0) 12 (1.5) 7 (1.5) 4 (1.5)
Others, n(%) 63 (24.3) 11 (10.6) 43 (34.4) 149 (18.8) 50 (11.0) 83 (30.6)
*P values were calculated with the use of Student's t-test. SS, severe sepsis/septic shock; ICU, intensive care unit; SOFA, sequential organ failure assessment; APACHE II, the 
acute physiology and chronic health evaluation; ICH, intracerebral hemorrhage; CI, cerebral infarction; CPAOA, cardiopulmonary arrest on arrival; SD, standard deviation.  
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Table 2 ： Severe sepsis/septic shock (SS) patient's baseline characteristics with regard to IRGM(+313) (rs10065172) genotypes
Discovery cohort Multi-center validation cohort
All CC+CT TT P value* All CC+CT TT P value*
(n=125) (n=112) (n=13) (n=268) (n=242) (n=26)
Age (yaers), mean±SD 57±17 56.7±17.3 65.1±14.4 0.097 66±15 67±15 67±15.3 0.861 
Male/female gender, n 69/56 61/51 8/5 0.771 173/95 155/87 18/8 0.671 
Length of ICU stay (days), mean±SD 18.4±22.0 19.2±22.9 11.7±8.8 0.243 26.3±35 26.3±35.7 24.6±26 0.811 
SOFA score, mean±SD 10.3±4.6 10.0±4.5 12.5±5.1 0.076 9.4±4.2 9.4±4.2 10.8±4.1 0.094 
APACHE II score, mean±SD 21.9±8.3 21.3±8.1 26.5±8.1 0.031 21.8±8.0 21.9±7.9 21.4±8.4 0.758 
Mortality (%) 29.6 26.8 53.8 0.012 25.4 23.6 42.3 0.036 
*P values were calculated with the use of Student's t-test. SS, severe sepsis/septic shock; ICU, intensive care unit; SOFA, sequential organ failure assessment; 
APACHE II, the acute physiology and chronic health evaluation; SD, standard deviation.
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Table 3 ： Genotype distributions
IRGM(+313) genotypes
SS patients 
n (%)
Non-sepsis patients 
n (%)
Healthy volunteers
n (%)
CC 164 (41.7) 242 (43.7) 144 (41.5)
CT 190 (48.3) 245 (44.3) 163 (47.0)
TT 39 (9.92) 66 (11.9) 40 (11.5)
SS, severe sepsis/septic shock
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Table 4 ： IRGM(+313) mRNA expression of whole blood with LPS challenge in healthy volunteers
IRGM(+313) genotypes CC CT TT
(n=70) (n=33) (n=33) (n=4)
Mean ⊿RQ 1.427 0.6702 -0.3465
Std. Error 0.5809 0.1702 0.1133
P=0.019 with Mann-Whitney U test ((CC+CT) v TT)
RQ, relative quantification; ⊿RQ, (post-stimulation)-(pre-stimulation with LPS)
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